Q3 2025 Earnings Call November 12, 2025 8:30 AM ESTCompany ParticipantsJoseph Racanelli - Vice President of Investor Relations ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced it will participate at the 2025 Maxim ...

Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 ...

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...

This free rollout of advanced AI models might be less about charity and more about securing a long-term hold on one of the ...

Chaoyang District has signed cooperation projects worth RMB 19.5 billion, opening a new chapter in bilateral relations ...

Gross profit and gross margins were $19.8 million and 42%, respectively, in the third quarter of 2025, compared to $17.2 million and 41%, respectively, in the third quarter of 2024. The increase in ...

The MarketWatch News Department was not involved in the creation of this content.-- Omlyclo(TM) (omalizumab) is the first and only omalizumab biosimilar approved in Europe -- Omly ...

Full three-month financial consolidation of a European e-vapor company contributed this quarter. Channel Innovation -- ...

Antimicrobial resistance (AMR) causes over 35,000 deaths annually in the EU/EEA and is projected to result in 1.91 million ...

Downtown Design, the Middle East's leading design fair for quality and contemporary design opens today, alongside Editions ...

Adrian Biggs has spent more than 15 years shaping global cocktail culture, drawing on a career that spans fine dining, craft ...